DOCSLIB.ORG

PFK-2/Fbpase-2: Maker and Breaker of the Essential Biofactor Fructose-2, 6-Bisphosphate

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PFK-2/Fbpase-2: Maker and Breaker of the Essential Biofactor Fructose-2, 6-Bisphosphate 30 Review TRENDS in Biochemical Sciences Vol.26 No.1 January 2001 PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate DavidA. Okar, Ànna Manzano,Aurèa Navarro-Sabatè, Lluìs Riera, Ramon Bartrons and Alex J. Lange Fructose-2,6-bisphosphate is responsible for mediating glucagon-stimulated extraction in base led to the discovery of F-2,6-P2 and gluconeogenesis in the liver.This discovery has led to the realization that this the realization that it was either formed or destroyed compound plays a significant role in directing carbohydrate fluxes in all during metabolic transitions where its concentration eukaryotes. Biophysical studies of the enzyme that both synthesizes and determined changes in glycolytic and gluconeogenic degrades this biofactor have yielded insight into its molecular enzymology. carbon flux in the liver. Interest in this compound grew Moreover, the metabolic role of fructose-2,6-bisphosphate has great potential rapidly because it was found to be a most potent in the treatment of diabetes. positive allosteric effector of 6-phosphofructo-1- kinase (PFK-1; EC 2.7.1.11) and an inhibitor of A trail that began with the discovery of a highly potent fructose-1,6-bisphosphatase (FBPase-1; EC 3.1.3.11). regulator of mammalian hepatic carbohydrate Because of its antagonistic actions on these enzymes, metabolism, fructose-2,6-bisphosphate (F-2,6-P2), led F-2,6-P2 plays a crucial role in the control of the to the discovery of the bifunctional enzyme opposing hepatic glycolytic and gluconeogenic 6-phosphofructo-2-kinase/fructose- pathways1–4 (Fig. 1). Because glycolysis requires the 2,6-bisphosphatase (PFK-2/FBPase-2) that is presence of F-2,6-P2, it is important in all glycolysis- responsible for both the formation and degradation of dependent tissues and it has since been found in this compound, and to the genes that code for it. Since virtually every eukaryotic tissue or cell examined5. the discovery of this system in liver, other mammalian Whether it is a fungus switching to an alternative tissue-specific bifunctional isozymes and their genes carbon source, a turtle hatchling freezing in a nest or a have been identified. F-2,6-P2 and the enzymes germinating seed, F-2,6-P2 is intimately involved in the responsible for controlling the amount of this biofactor metabolic fine tuning required for survival. appear to be present in all eukaryotes, including A single enzyme family is responsible for plants and yeast. Although the particular function of determining the levels of F-2,6-P2 by synthesizing and F-2,6-P2 in each cell type varies to some extent, degrading this compound at distinct active sites. That adaptation to changing environmental or metabolic is, the kinase (EC 2.7.1.105) synthesizes F-2,6-P2 from situations is a common theme and this implies that a ATP and fructose-6-phosphate (F-6-P), whereas the diversity of mechanisms have evolved to control the bisphosphatase (EC 3.1.3.46) degrades F-2,6-P2 to relative kinase (synthetic) and bisphosphatase F-6-P and inorganic phosphate (Pi). It should be (degradative) activities. The most striking example of appreciated not only that the enzyme catalyzes this diversity is the yeast, which do not express a reciprocal reactions, but also that it does so as a dimer bifunctional enzyme, rather they use a set of enzymes that is stabilized by numerous protein–protein David A. Okar 6 Alex J. Lange* that have one or the other activity diminished by interactions between the kinase domains (Fig. 2) . By Dept of Biochemistry, ‘mutation’ of key catalytic amino acid residues in the contrast, the crystal structure of the rat testis Molecular Biology and kinase or bisphosphatase active sites. This highlights bifunctional enzyme suggests that the bisphosphatase Biophysics, University of Minnesota, Minneapolis, the complexity of this convoluted signaling enzyme domains have little, if any, contact across the dimeric MN 55455, USA. system, which is an essential determinant in the interface. This view is supported by the observation *e-mail: regulation of carbohydrate metabolism. that the separately expressed rat liver bisphosphatase [email protected] domain is monomeric, even at greater than 4 mM Ànna Manzano A multimodulated bifunctional enzyme (80 mg ml−1)7. The quaternary structure of the rat Aurea Navarro-Sabatè F-2,6-P was discovered during the search for the bifunctional enzyme is relevant to the monofunctional Lluìs Riera 2 Ramon Bartrons mechanism by which glucagon stimulates hepatic yeast isozymes because they retain the two domain 8,9 Unitat de Bioquímica, gluconeogenesis. The fact that it does not participate as structure of the monomers and are dimeric . Campus de Bellvitge, an intermediary in any metabolic interconversion, as However, the ‘monofunctionality’ refers to the subunits Universitat de Barcelona, well as its lability in acid extracts used in systematic of the dimer. Considering that the expression of a C/Feixa Llarga, S/N, 08907 L’Hospitalet, Barcelona, surveys of phosphoric acid esters in tissues, explains single yeast isozyme is not exclusive, it is possible that Spain. why it escaped discovery until 1980. Eventually, the yeast enzymes demonstrate bifunctionality by http://tibs.trends.com 0968-0004/01/$ – see front matter © 2001 Elsevier Science Ltd. All rights reserved. PII: S0968-0004(00)01699-6 Review TRENDS in Biochemical Sciences Vol.26 No.1 January 2001 31 (cAMP)-dependent protein kinase cascade set off by Glucose glucagon binding to the extracellular site of its receptor. This compound forms the juncture between the hormonal signal pathway and the metabolic pathway. GK Glu-6-Pase Because both the Km of PFK-2 and the Ki of FBPase-2 for F-6-P are in the physiological range, any alteration of F-6-P concentration should cause inverse changes in the two activities. The reciprocal modulation of the Glucose 6-P kinase and bisphosphatase activities forms the current paradigm for explaining how the bifunctional enzyme can closely regulate the level of F-2,6-P in vivo. Fructose 6-P 2 The kinase reaction proceeds by a sequential- PFK-2/FBPase-2 ordered mechanism for transfer of the phosphate from ATP to F-6-P. The bisphosphatase reaction proceeds via K K PKA KK a covalent phosphohistidine intermediate formed upon Citrate Gly-3-P Gly-3-P_ BB reaction with F-2,6-P . In isolation, neither reaction is BB + Pi 2 PEP freely reversible. The steady state concentration of PP2A F-2,6-P is determined by the balance between these PFK-1 FBPase-1 2 opposing reactions. This kinase:bisphosphatase activity Fructose 2,6-P2 _ ratio (K:B) is the most salient aspect of any given + bifunctional enzyme isoform, whether the active sites reside on the same monomeric component or not, because the balance between the reciprocal reactions is Fructose 1,6-P what determines the net effect on the cellular content of + 2 F-2,6-P2. The K:B is determined by which isoforms are present, the levels of several glycolytic and PEP gluconeogenic metabolites, post-translational PEPCK modification of the enzyme, and even xylulose-5- phosphate, an intermediate of the hexose PK OAA monophosphate pathway. Metabolites beyond PFK-1, such as α-glycerol phosphate, phosphoenolpyruvate and citrate decrease the activity of PFK-2 or favor that of FBPase-2, in accordance with Pyruvate the concept of a negative feed-back control loop11,12. In addition, the bisphosphatase activity is modulated by Lactate, alanine Ti BS GTP and ATP, which activate FBPase-2 at subsaturating substrate concentrations, but inhibit Fig. 1.The position of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) in competitively at saturating substrate concentrations13. the pathways of hepatic intermediary carbohydrate metabolism. Regulation of PFK-2/FBPase-2 The vast range of signals impinging upon the target activities, 6-phosphofructo-1-kinase (PFK-1) and fructose-1,6-bisphosphatase (FBPase-1), as bifunctional enzyme constitute the enzyme’s well as regulation of PFK-2/FBPase-2 itself via effectors and covalent modification are shown. Abbreviations: Gly-3-P, glyceraldehyde-3-phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; multimodality and, together, determine the overall K:B PEPCK, PEP carboxykinase; P , inorganic phosphate; PK, pyruvate kinase; PKA, protein kinase A; i and thereby the F-2,6-P2 content of the living PP2A, protein phosphatase 2A. 1–5,11,12,14,15 cell . The significance of F-2,6-P2 with regard forming mixed dimers in which the monomers possess to carbohydrate flux has been exploited to lower the reciprocal kinase and bisphosphatase activities. blood glucose levels in streptozotocin-treated mice, Several years ago, Sols et al. described the concept of which model type I diabetes. This was done using enzyme multimodulation arising from the adenovirus-mediated overexpression of the rat liver accumulation of several regulatory mechanisms in a bifunctional enzyme engineered to have a high K:B given enzyme10. These regulatory mechanisms can be of (Ref. 16). The engineered enzyme has two mutations, different types (cooperative, allosteric or Ser32Ala and His258Ala, which remove a regulatory interconversion), of the same type (multiple allosteric phosphorylation site and a key component of the effects) or of any combination. PFK-2/FBPase-2 has bisphosphatase active site, respectively. many of these properties, making it responsive to a Overexpression of the high K:B bifunctional enzyme plethora of metabolic and hormonal signals. This is markedly stimulated glucokinase (GK) expression and consistent with its central role in regulation of diminished that of glucose-6-phosphatase (G-6-Pase). carbohydrate metabolic fluxes in a diverse cross-section This indicates that the cellular effects of F-2,6-P2 are of tissue types and eukaryotic life-forms.
Load more

Recommended publications
  • Structural Study of the Acid Sphingomyelinase Protein Family
    Structural Study of the Acid Sphingomyelinase Protein Family Alexei Gorelik Department of Biochemistry McGill University, Montreal August 2017 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Doctor of Philosophy © Alexei Gorelik, 2017 Abstract The acid sphingomyelinase (ASMase) converts the lipid sphingomyelin (SM) to ceramide. This protein participates in lysosomal lipid metabolism and plays an additional role in signal transduction at the cell surface by cleaving the abundant SM to ceramide, thus modulating membrane properties. These functions are enabled by the enzyme’s lipid- and membrane- interacting saposin domain. ASMase is part of a small family along with the poorly characterized ASMase-like phosphodiesterases 3A and 3B (SMPDL3A,B). SMPDL3A does not hydrolyze SM but degrades extracellular nucleotides, and is potentially involved in purinergic signaling. SMPDL3B is a regulator of the innate immune response and podocyte function, and displays a partially defined lipid- and membrane-modifying activity. I carried out structural studies to gain insight into substrate recognition and molecular functions of the ASMase family of proteins. Crystal structures of SMPDL3A uncovered the helical fold of a novel C-terminal subdomain, a slightly distinct catalytic mechanism, and a nucleotide-binding mode without specific contacts to their nucleoside moiety. The ASMase investigation revealed a conformational flexibility of its saposin domain: this module can switch from a detached, closed conformation to an open form which establishes a hydrophobic interface to the catalytic domain. This open configuration represents the active form of the enzyme, likely allowing lipid access to the active site. The SMPDL3B structure showed a narrow, boot-shaped substrate binding site that accommodates the head group of SM.
    [Show full text]
  • The Role of Triacylglycerol in Plant Stress Response
    plants Review The Role of Triacylglycerol in Plant Stress Response Junhao Lu 1, Yang Xu 1, Juli Wang 1, Stacy D. Singer 2,* and Guanqun Chen 1,* 1 Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, T6G 2P5 Alberta, Canada; [email protected] (J.L.); [email protected] (Y.X.); [email protected] (J.W.) 2 Agriculture and Agri-Food Canada, Lethbridge Research and Development Centre, Lethbridge, T1J 4B1 Alberta, Canada * Correspondence: [email protected] (S.D.S.); [email protected] (G.C.); Tel.: +1-403-317-3386 (S.D.S.); +1-780-492-3148 (G.C.) Received: 4 March 2020; Accepted: 2 April 2020; Published: 8 April 2020 Abstract: Vegetable oil is mainly composed of triacylglycerol (TAG), a storage lipid that serves as a major commodity for food and industrial purposes, as well as an alternative biofuel source. While TAG is typically not produced at significant levels in vegetative tissues, emerging evidence suggests that its accumulation in such tissues may provide one mechanism by which plants cope with abiotic stress. Different types of abiotic stress induce lipid remodeling through the action of specific lipases, which results in various alterations in membrane lipid composition. This response induces the formation of toxic lipid intermediates that cause membrane damage or cell death. However, increased levels of TAG under stress conditions are believed to function, at least in part, as a means of sequestering these toxic lipid intermediates. Moreover, the lipid droplets (LDs) in which TAG is enclosed also function as a subcellular factory to provide binding sites and substrates for the biosynthesis of bioactive compounds that protect against insects and fungi.
    [Show full text]
  • The Crystal Structure of the Bifunctional Enzyme 6-Phosphofructo-2-Kinase
    Research Article 1017 The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies Charles A Hasemann†*, Eva S Istvan1, Kosaku Uyeda1,2 and Johann Deisenhofer1,3 Background: Glucose homeostasis is maintained by the processes of Addresses: 1Department of Biochemistry, glycolysis and gluconeogenesis. The importance of these pathways is University of Texas Southwestern Medical Center, demonstrated by the severe and life threatening effects observed in various 5323 Harry Hines Blvd., Dallas, TX 75235 USA, 2Research Service, Department of Veterans Affairs forms of diabetes. The bifunctional enzyme 6-phosphofructo-2-kinase/fructose- Medical Center, 4500 S. Lancaster Rd., Dallas, 2,6-bisphosphatase catalyzes both the synthesis and degradation of fructose- TX, 75216 USA and 3Howard Hughes Medical 2,6-bisphosphate, a potent regulator of glycolysis. Thus this bifunctional enzyme Institute, University of Texas, Southwestern plays an indirect yet key role in the regulation of glucose metabolism. Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235, USA. Results: We have determined the 2.0 Å crystal structure of the rat testis †Present address: Department of Internal isozyme of this bifunctional enzyme. The enzyme is a homodimer of 55 kDa Medicine, Division of Rheumatology, and the subunits arranged in a head-to-head fashion, with each monomer consisting of Harold C Simmons Center for Arthritis Research, University of Texas Southwestern Medical Center, independent kinase and phosphatase domains. The location of ATPgS and 5323 Harry Hines Blvd., Dallas, TX 75235-8884, inorganic phosphate in the kinase and phosphatase domains, respectively, allow USA. us to locate and describe the active sites of both domains.
    [Show full text]
  • Genomics of Inherited Bone Marrow Failure and Myelodysplasia Michael
    Genomics of inherited bone marrow failure and myelodysplasia Michael Yu Zhang A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2015 Reading Committee: Mary-Claire King, Chair Akiko Shimamura Marshall Horwitz Program Authorized to Offer Degree: Molecular and Cellular Biology 1 ©Copyright 2015 Michael Yu Zhang 2 University of Washington ABSTRACT Genomics of inherited bone marrow failure and myelodysplasia Michael Yu Zhang Chair of the Supervisory Committee: Professor Mary-Claire King Department of Medicine (Medical Genetics) and Genome Sciences Bone marrow failure and myelodysplastic syndromes (BMF/MDS) are disorders of impaired blood cell production with increased leukemia risk. BMF/MDS may be acquired or inherited, a distinction critical for treatment selection. Currently, diagnosis of these inherited syndromes is based on clinical history, family history, and laboratory studies, which directs the ordering of genetic tests on a gene-by-gene basis. However, despite extensive clinical workup and serial genetic testing, many cases remain unexplained. We sought to define the genetic etiology and pathophysiology of unclassified bone marrow failure and myelodysplastic syndromes. First, to determine the extent to which patients remained undiagnosed due to atypical or cryptic presentations of known inherited BMF/MDS, we developed a massively-parallel, next- generation DNA sequencing assay to simultaneously screen for mutations in 85 BMF/MDS genes. Querying 71 pediatric and adult patients with unclassified BMF/MDS using this assay revealed 8 (11%) patients with constitutional, pathogenic mutations in GATA2 , RUNX1 , DKC1 , or LIG4 . All eight patients lacked classic features or laboratory findings for their syndromes.
    [Show full text]
  • Pectinesterase, Polygalacturonase
    HORTSCIENCE 27(8):900-902. 1992. of 8.2% SSC from the Dept. of Scientific and Industrial Research (DSIR) Research Orchard at Te Puke, New Zealand, then Pectinesterase, Polygalacturonase, and treated within 6 h with ethylene (16 h, 1000 µl·liter-1, 20C) and ripened at 20C in trays b -galactosidase during Softening of provided with polyethylene liners. Samples were taken before ethylene treatment and at Ethylene-treated Kiwifruit 1, 2, and 5 days after treatment. As the 1988 fruit were already quite soft at the time of Teresa F. Wegrzyn and Elspeth A. MacRae the first sampling, ethylene dosage and sam- Department of Scientific and Industrial Research, Fruit and Trees, pling times were altered for the following Private Bag, Auckland I, New Zealand season. In 1989, fruit from the DSIR Re- search Orchard at Kumeu, New Zealand, was Additional index words. ethylene, fruit softening, cell wall, Actinidia deliciosa harvested at 7.2% SSC, then treated and rip ened as for 1988 fruit, except that ethylene Abstract. The activities of several cell wall-associated enzymes of the outer pericarp treatment was for 18 h at 100 µl·liter-1, and were assayed during softening of kiwifruit [Actinidia deliciosa (A. Chev.) C.F. Liang fruit samples were also taken immediately et A.R. Ferguson var. deliciosa cv. Hayward] treated with ethylene. The activity of after ethylene treatment and at 10 days after polygalacturonase (EC 3.2.1.15) increased slightly during fruit softening, while b- harvest. galactosidase (EC 3.2.1.23) activity remained constant. Salt-extracted pectinesterase (EC 3.1.1.11) activity increased during ethylene treatment, then dropped rapidly to In both years, five replicates were made low levels as fruit softened.
    [Show full text]
  • A Review of Phosphatidate Phosphatase Assays
    REVIEW A review of phosphatidate phosphatase assays Prabuddha Dey1, Gil-Soo Han1 , and George M. Carman1,* 1Department of Food Science and the Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, NJ, USA Abstract Phosphatidate phosphatase (PAP) catalyzes the ganisms studied thus far, PAP activity is dependent on the penultimate step in the synthesis of triacylglycerol and regu- DXDX(T/V) catalytic motif in the haloacid dehalogenase- lates the synthesis of membrane phospholipids. There is like domain (10, 13, 14). The enzyme is extensively modi- much interest in this enzyme because it controls the cellular fied posttranslationally by phosphorylation, which acutely levels of its substrate, phosphatidate (PA), and product, regulates its catalytic activity, subcellular localization, and DAG; defects in the metabolism of these lipid intermediates are the basis for lipid-based diseases such as obesity, lipodys- protein stability (15–17). Downloaded from trophy, and inflammation. The measurement of PAP activity is PAP is a key lipid metabolic enzyme that is required for required for studies aimed at understanding its mechanisms the synthesis of the neutral lipid triacylglycerol (TAG) and of action, how it is regulated, and for screening its activators major membrane phospholipids (16–18) (Fig. 1). The en- and/or inhibitors. Enzyme activity is determined through zyme product, DAG, is a direct precursor of TAG (16, 19–22), the use of radioactive and nonradioactive assays that measure whereas its substrate, PA, is a direct precursor of the lipo- the product, DAG, or Pi. However, sensitivity and ease of use nucleotide, CDP-DAG, a key intermediate in phospholipid www.jlr.org are variable across these methods.
    [Show full text]
  • Defensive Forwards: Stress-Responsive Proteins in Cell Walls of Crop Plants
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.15.950535; this version posted February 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 Short communication 2 3 Defensive forwards: stress-responsive proteins in cell walls of crop plants 4 5 Liangjie Niu, Wei Wang* 6 7 National Key Laboratory of Wheat & Maize Crop Science, College of Life Sciences, Henan 8 Agricultural University, Zhengzhou 450002, China 9 10 *Corresponding author. Wei Wang, College of Life Sciences, Henan Agricultural University, 11 Zhengzhou 450002, China. E-mail:[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.15.950535; this version posted February 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 12 ABSTRACT 13 As the vital component of plant cell wall, proteins play important roles in stress response 14 through modifying wall structure and involving in wall integrity signaling. However, the 15 potential of cell wall proteins (CWPs) in improvement of crop stress tolerance has probably 16 been underestimated. Recently, we have critically reviewed the predictors, databases and 17 cross-referencing of subcellular locations of possible CWPs in plants (Briefings in 18 Bioinformatics 2018;19:1130-1140).
    [Show full text]
  • The Role of Chloroplast Membrane Lipid Metabolism in Plant Environmental Responses
    cells Review The Role of Chloroplast Membrane Lipid Metabolism in Plant Environmental Responses Ron Cook 1,2,†, Josselin Lupette 1,†,‡ and Christoph Benning 1,2,3,* 1 MSU-DOE Plant Research Laboratory, Michigan State University, East Lansing, MI 48824-1319, USA; [email protected] (R.C.); [email protected] (J.L.) 2 Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824-1319, USA 3 Department of Plant Biology, Michigan State University, East Lansing, MI 48824-1319, USA * Correspondence: [email protected] † These authors contributed equally to this work. ‡ Present address: Laboratoire de Biogenèse Membranaire, Université de Bordeaux, CNRS, UMR 5200, F-33140 Villenave d’Ornon, France. Abstract: Plants are nonmotile life forms that are constantly exposed to changing environmental conditions during the course of their life cycle. Fluctuations in environmental conditions can be drastic during both day–night and seasonal cycles, as well as in the long term as the climate changes. Plants are naturally adapted to face these environmental challenges, and it has become increasingly apparent that membranes and their lipid composition are an important component of this adaptive response. Plants can remodel their membranes to change the abundance of different lipid classes, and they can release fatty acids that give rise to signaling compounds in response to environmental cues. Chloroplasts harbor the photosynthetic apparatus of plants embedded into one of the most extensive membrane systems found in nature. In part one of this review, we focus on changes in chloroplast membrane lipid class composition in response to environmental changes, and in part two, we will detail chloroplast lipid-derived signals.
    [Show full text]
  • Induced Glycosaminoglycan and Sphingolipid Accumulation
    Proc. Natl. Acad. Sci. USA Vol. 77, No. 6, pp. 3700-3704, June 1980 Medical Sciences Experimental animal model for mucopolysaccharidosis: Suramin- induced glycosaminoglycan and sphingolipid accumulation in the rat (neuronal inclusions/lysosomal enzymes/noncompetitive inhibition/ganglioside storage) GEORGE CONSTANTOPOULOS*, SANDRA REESt, B. G. CRAGGt, JOHN A. BARRANGER*, AND ROSCOE 0. BRADY* *Developmental and Metabolic Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20205; and tDepartment of Physiology, Monash University, Clayton, Victoria, 3168, Australia Contributed by Roscoe 0. Brady, March 20, 1980 ABSTRACG Intracerebral injection of the trypanocidal drug (Streptomyces griseus protease, B grade) from Calbiochem. suramin in rats caused the formation of membranous neuronal GAG standards were supplied by Martin B. Mathews, Uni- and neuroglial inclusions. Here we show that intravenous ad- were ministration of suramin, 500 mg/kg, to 2-month-old rats causes versity of Chicago. p-Nitrophenyl glycosides purchased a 5- to 8-fold increase of glycosaminoglycan concentration in from Sigma and Research Products International (Elk Grove the liver within 10 days and a 6-fold increase in urinary gly- Village, IL). Phenyl-a-L-iduronide was a gift from B. Weiss- cosaminoglycan excretion. The excess glycosaminoglycans mann of the University of Illinois College of Medicine, and consist of heparan sulfate and dermatan sulfate. Intracerebral 0-(a-L-idopyranosyluronic acid 2-sulfate)-2,5-anhydro-D- injection of 250 Ag of suramin results in a small increase of [3H]mannitol 6-sulfate was prepared from heparin (7). [N- glycosaminoglycan and larger increase of ganglioside Gm2, GM3, and GD3 concentrations in the treated region of the brain.
    [Show full text]
  • United States Patent 19) 11 Patent Number: 5,436,143 Hyman - 45 Date of Patent: Jul
    US005436143A United States Patent 19) 11 Patent Number: 5,436,143 Hyman - 45 Date of Patent: Jul. 25, 1995 54 METHOD FORENZYMATICSYNTHESIS OF cleotides', in Oligonucleotide Synthesis: A Practical Ap OLGONUCLEOTIOES proach, M. J. Gait ed., pp. 185-197 (1984). Mudrakovskaya et al., “RNA Ligase of Bacteriophage 76 Inventor: Edward D. Hyman, 2100 Sawmill T4. VII: A solid pahse enymatic synthesis of Rd., Apt. 4-103, River Ridge, La. oligoribonucelotides', Biorg. Khim., 17: 819-822 701.23 (1991). (21) Appl. No.: 995,791 Stuart et al., “Synthesis and Properties of Oligodeox ynucleotides with an AP site at a preselected location', 22 Filed: Dec. 23, 1992 Nulceic Acids Res. 15: 7451-7462 (1987). 51) Int. Cl. .............................................. C12P 19/34 Norton et al., "A ribonuclease specific for 2'-O-Me 52 U.S. C. .................................. 435/91.2; 435/91.1; thyltaed Ribonulceic Acid', J. Biol. Chem. 242: 435/91.21; 435/91.3; 435/91.31; 435/91.5; 2029-2034 (1967). 435/91.51; 435/91.52; 536/24.33; 536/25.3; Eckstein et al., “Phosphorothioates in molecular biol 536/25.31; 935/16: 935/88 ogy”, TIBS 14:97-100 (1989). 58) Field of Search ................... 435/91, 6, 91.1, 91.2, Bryant et al., “Phosphorothioate Substrates for T4 435/91.21, 91.3, 91.31, 91.5, 91.51, 91.52; RNA Ligase', Biochemistry 21:5877-5885 (1982). 536/25.3, 25.6, 24.33, 25.31; 935/16, 88 McLaughlin et al., “Donor Activation in the TS RNA Ligase Reaction', Biochemistry 24: 267-273 (1985). (56) References Cited Ohtsuka et al., “A new method for 3'-labelling of U.S.
    [Show full text]
  • Human Acid Sphingomyelinase Structures Provide Insight to Molecular Basis of Niemann-Pick Disease Yan-Feng Zhou Analytical Discovery Therapeutics
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Biochemistry & Molecular Biology Department Biochemistry and Molecular Biology Faculty Publication Series 2016 Human Acid Sphingomyelinase Structures Provide Insight to Molecular Basis of Niemann-Pick Disease Yan-Feng Zhou Analytical Discovery Therapeutics Matthew .C Metcalf University of Massachusetts Amherst Scott .C Garman University of Massachusetts Amherst Tim Edmunds Sanofi Huawei Qiu Sanofi See next page for additional authors Follow this and additional works at: https://scholarworks.umass.edu/biochem_faculty_pubs Part of the Biochemistry Commons Recommended Citation Zhou, Yan-Feng; Metcalf, Matthew C.; Garman, Scott .;C Edmunds, Tim; Qiu, Huawei; and Wei, Ronnie R., "Human Acid Sphingomyelinase Structures Provide Insight to Molecular Basis of Niemann-Pick Disease" (2016). Nature Communications. 8. 10.1038/ncomms13082 This Article is brought to you for free and open access by the Biochemistry and Molecular Biology at ScholarWorks@UMass Amherst. It has been accepted for inclusion in Biochemistry & Molecular Biology Department Faculty Publication Series by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. Authors Yan-Feng Zhou, Matthew C. Metcalf, Scott .C Garman, Tim Edmunds, Huawei Qiu, and Ronnie R. Wei This article is available at ScholarWorks@UMass Amherst: https://scholarworks.umass.edu/biochem_faculty_pubs/8 ARTICLE Received 23 Feb 2016 | Accepted 1 Sep 2016 | Published 11 Oct 2016 DOI: 10.1038/ncomms13082 OPEN Human acid sphingomyelinase structures provide insight to molecular basis of Niemann–Pick disease Yan-Feng Zhou1,w, Matthew C. Metcalf2, Scott C. Garman2, Tim Edmunds1, Huawei Qiu1 & Ronnie R. Wei1 Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and phosphocholine, essential components of myelin in neurons.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]